硬皮病在颅内动脉瘤病理生理中的双重可能作用:病例报告与文献复习
本文通过1例新发病例并结合文献复习,汇总11例硬皮病合并颅内动脉瘤患者共26个动脉瘤。可获取数据中35%动脉瘤≥1 cm,12%为巨大动脉瘤,15%为梭形。45%以蛛网膜下腔出血起病。作者推测硬皮病可能促进动脉瘤形成,但胶原异常增生或可保护其免于早期破裂而长至较大体积。
要点
- 硬皮病合并颅内动脉瘤者多发动脉瘤比例高,需全面筛查。
- 此类动脉瘤可长至较大体积,梭形动脉瘤占一定比例。
- 近半数以蛛网膜下腔出血起病,破裂风险不可忽视。
核心结论
- 硬皮病可能参与颅内动脉瘤形成,但胶原异常生长或可延缓早期破裂而允许动脉瘤增大。
研究设计与样本
- 病例报告联合文献复习,共纳入11例硬皮病合并颅内动脉瘤患者、26个动脉瘤。
主要发现
- 可获取数据中35%的动脉瘤≥1 cm,其中12%为巨大动脉瘤。
- 梭形动脉瘤4个,占15%。
- 45%的病例以蛛网膜下腔出血起病。
临床怎么用
- 对硬皮病患者应关注颅内动脉瘤筛查,尤其注意多发与较大体积动脉瘤。
- 合并蛛网膜下腔出血起病者需按动脉瘤性出血规范处理。
局限性
- 基于病例报告与文献复习的小样本汇总,证据级别有限。
- 部分动脉瘤特征数据不可获取,比例基于可获取数据计算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Scleroderma, or systemic sclerosis, is an autoimmune disorder affecting connective tissues, including blood vessels. Although the exact mechanism is not understood, it results in the production of an abnormal amount of collagen. Cases have been reported in which patients with scleroderma also had intracranial aneurysms. We wish to gain insight into any potential association between the 2 diseases. CASE DESCRIPTION: We reviewed the literature of scleroderma cases with cerebral aneurysms and added our own case, focusing on patient and aneurysm characteristics. Including the present case, this paper pertains to 11 cases with 26 aneurysms. Fifty-five percent had multiple aneurysms, of which two thirds had >2. When data were available, 35% of aneurysms were ≥1 cm, 12% of which were giant. Four aneurysms were fusiform (15%). Patients presented with subarachnoid hemorrhage in 45% of cases. CONCLUSIONS: Scleroderma may lead to the formation of an aneurysm, and the abnormal growth of collagen may protect it from early rupture, allowing it to reach a large size.
引用
- Jabre R, Benomar A, Bojanowski MW, et al. Scleroderma's Possible Dual Role in the Pathophysiology of Intracranial Aneurysms: Case Report and Literature Review. World Neurosurg. 2020. PMID: 32461175. doi:10.1016/j.wneu.2020.05.170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。